| Literature DB >> 35173428 |
Yuchen Gao1, Chunrong Wang1, Yuefu Wang2, Jun Li1, Jianhui Wang1, Sudena Wang1, Yu Tian1, Jia Liu1, Xiaolin Diao3, Wei Zhao3.
Abstract
BACKGROUND: Hospital-acquired infection (HAI) after cardiac surgery is a common clinical concern associated with adverse prognosis and mortality. The objective of this study is to determine the prevalence of HAI and its associated risk factors in elderly patients following cardiac surgery and to build a nomogram as a predictive model.Entities:
Keywords: model; nosocomial infection; older patients; prediction
Mesh:
Year: 2022 PMID: 35173428 PMCID: PMC8841270 DOI: 10.2147/CIA.S351226
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 4.458
Figure 1Flow chart of the study cohort.
Patients Characteristics
| Variable | Total (n = 6405) | No HAI (n = 6154) | HAI (n = 251) | |
|---|---|---|---|---|
| Male | 4276 (66.76) | 4101 (66.64) | 175 (69.72) | 0.339 |
| Age (years) | 73.60 (2.81) | 73.59 (2.82) | 73.75 (2.69) | 0.374 |
| BMI (kg/m2) | 24.78 (3.12) | 24.79 (3.13) | 24.42 (2.92) | 0.064 |
| Smoking (yes) | 2756 (43.03) | 2628 (42.70) | 128 (51.00) | 0.011 |
| Hypertension (yes) | 4128 (64.45) | 3964 (64.41) | 164 (65.34) | 0.788 |
| Diabetes (yes) | 1858 (29.01) | 1773 (28.81) | 85 (33.86) | 0.089 |
| Hyperlipidemia (yes) | 3461 (54.04) | 3329 (54.09) | 132 (52.59) | 0.651 |
| MI (yes) | 882 (13.77) | 828 (13.45) | 54 (21.51) | 0.001 |
| Atrial fibrillation (yes) | 699(10.91) | 660(10.72) | 39(15.54) | 0.022 |
| PVD (yes) | 858 (13.40) | 814 (13.23) | 44 (17.53) | 0.058 |
| Stroke (yes) | 1905 (29.74) | 1819 (29.56) | 86 (34.26) | 0.121 |
| COPD (yes) | 377 (5.89) | 363 (5.90) | 14 (5.58) | 0.832 |
| Anemia (yes) | 2435 (38.02) | 2331 (37.88) | 104 (41.43) | 0.260 |
| Previous cardiac surgery (yes) | 197 (3.08) | 182 (2.96) | 15 (5.98) | 0.013 |
| CPB (yes) | 3744 (58.45) | 3567 (57.96) | 177 (70.52) | <0.001 |
| CPB time (minutes) | 101[81–128] | 101[81–127] | 110[86–144] | 0.002 |
| ACCT (minutes) | 71[54–92] | 70[53–91] | 78[55–104] | 0.006 |
| Erythrocytes transfusion (yes) | 2145 (33.49) | 2028 (32.95) | 117 (46.61) | <0.001 |
| FFP transfusion (yes) | 858 (13.40) | 812 (13.19) | 46 (18.33) | 0.023 |
| Platelet transfusion (yes) | 309 (4.82) | 282 (4.58) | 27 (10.76) | <0.001 |
| Surgery type | 0.021 | |||
| Isolated CABG | 4527 (70.68) | 4368 (70.98) | 159 (63.35) | |
| Isolated valve | 877 (13.69) | 834 (13.55) | 43 (17.13) | |
| Aortic | 228 (3.58) | 221 (3.59) | 7 (2.79) | |
| Combined | 746 (11.65) | 704 (11.44) | 42 (16.73) | |
| Others | 27 (0.42) | 27 (0.44) | 0 (0) | |
| LVEF (%) | 60.46 (7.92) | 60.52 (7.90) | 58.83 (8.11) | 0.001 |
| NYHA | 0.429 | |||
| I | 578 (9.02) | 557 (9.05) | 21 (8.37) | |
| II | 3461 (54.04) | 3327 (54.06) | 134 (53.39) | |
| III | 2191 (34.21) | 2106 (34.22) | 85 (33.86) | |
| IV | 175 (2.73) | 164 (2.66) | 11 (4.38) | |
| Pre-operative hospitalization (days) | 7 [5–11] | 7 [5–11] | 7 [5–13] | 0.237 |
| MV time (hours) | 19 [16–27] | 19 [16–26] | 34 [19–91] | <0.001 |
| ICU days | 3 [2–5] | 3 [2–5] | 6 [4–8] | <0.001 |
| Total hospitalization (days) | 16 [13–21] | 16 [13–21] | 21 [15–30] | <0.001 |
Abbreviations: HAI, healthcare-associated infection; BMI, body mass index; MI, myocardial infarction; PVD, peripheral vascular disease; COPD; chronic pulmonary disease; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; CPB, cardiopulmonary bypass; ACCT, aortic cross clamp time; FFP fresh frozen plasma; CABG, coronary artery bypass graft surgery; MV, mechanical ventilation; ICU, intensive care unit.
Univariate and Multivariate Logistic Regression Analysis of Risk Factors for Healthcare-Associated Infection
| Variable | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|
| Odds Ratio (95% CI) | Odds Ratio* (95% CI) | |||
| Sex(male) | 1.153 (0.876–1.157) | 0.310 | ||
| Age | 1.020 (0.976–1.065) | 0.374 | ||
| BMI | 0.962 (0.923–1.002) | 0.064 | ||
| Smoking (yes vs no) | 1.396 (1.085–1.797) | 0.010 | 1.594 (1.222–2.080) | 0.001 |
| Hypertension (yes vs no) | 1.041 (0.799–1.358) | 0.764 | ||
| Diabetes (yes vs no) | 1.265 (0.969–1.653) | 0.084 | ||
| Hyperlipidemia (yes vs no) | 0.941 (0.731–1.212) | 0.639 | ||
| MI (yes vs no) | 1.763 (1.293–2.404) | <0.001 | 1.797 (1.279–2.526) | <0.001 |
| Atrial fibrillation (yes vs no) | 1.531 (1.078–2.175) | 0.017 | ||
| PVD (yes vs no) | 1.394 (0.999–1.947) | 0.051 | ||
| Stroke (yes vs no) | 1.242 (0.952–1.621) | 0.111 | ||
| COPD (yes vs no) | 0.942 (0.544–1.632) | 0.832 | ||
| Anemia (yes vs no) | 1.160(0.898–1.499) | 0.256 | ||
| Previous cardiac surgery (yes vs no) | 2.086 (1.213–3.587) | 0.008 | ||
| LVEF | 0.975 (0.961–0.990) | 0.001 | ||
| NYHA (III, IV) | 1.060 (0.817–1.374) | 0.662 | ||
| Pre-operative hospitalization (per week) | 1.207 (1.069–1.364) | 0.002 | 1.186 (1.044–1.346) | 0.009 |
| ACCT (per 30 min) | 1.215 (1.130–1.307) | <0.001 | ||
| CPB (yes vs no) | 1.735 (1.316–2.286) | <0.001 | 1.487 (1.108–1.995) | 0.008 |
| Erythrocytes transfusion (yes vs no) | 1.776 (1.378–2.289) | <0.001 | 1.540 (1.172–2.022) | 0.002 |
| FFP transfusion (yes vs no) | 1.476 (1.063–2.050) | 0.020 | ||
| Platelet transfusion (yes vs no) | 2.510 (1.654–3.808) | <0.001 | ||
| Surgery type | 1.146 (1.026–1.280) | 0.016 | ||
| MV time (per 24 hours) | 1.195 (1.157–1.233) | <0.001 | 1.177 (1.139–1.215) | <0.001 |
Notes: *Adjusted for previous cardiac surgery, diabetes, BMI, PVD, Atrial fibrillation, LVEF, CPB time, ACCT, FFP transfusion, surgery type and platelet transfusion.
Abbreviations: BMI, body mass index; MI, myocardial infarction; PVD, peripheral vascular disease; COPD; chronic pulmonary disease; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; CPB, cardiopulmonary bypass; ACCT, aortic cross clamp time; FFP, fresh frozen plasma; CABG, coronary artery bypass graft surgery; MV, mechanical ventilation; ICU, intensive care unit.
Figure 2Nomogram predicting the risk of HAIs based on independent risk factors identified from multivariate logistic regression analysis.
Figure 3The receiver operating characteristic curve and calibration curve. (A). ROC curve of the nomogram. (B). Calibration curve of derivation cohorts and internal bootstrap validation cohorts. In (B), X-axis is the nomogram-predicted probability; Y-axis is the actually observed probability. The dashed black line indicates a perfect prediction by an ideal model. The purple solid line represents the calibration of established nomogram, while blue solid line is bias-corrected with bootstrapping technique.
Figure 4Decision curve analyses for the HAIs nomogram. (A). The derivation cohort. (B). The internal bootstrap validation. Black solid line indicates net benefit of all patients developing HAIs postoperatively. Gray dotted line indicates net benefit of no patients developing HAIs postoperatively. Red and purple solid lines indicate net benefit of the nomogram derived from derivation cohorts and internal bootstrap validation cohorts.